Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FXH vs DLHIX overlap: 19% of top holdings shared

Bottom line

How much do FXH and DLHIX overlap?

19% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 13.5% of FXH's assets and 14.5% of DLHIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

FXHDLHIX
Weight overlap (top 25)19%
Shared holdings6
Weight in shared holdings13.5%14.5%
Total positions75108
Expense ratio0.61%0.96%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FXH and DLHIX have in common

Holding% of FXH% of DLHIXOverlap
Regeneron Pharmaceuticals Inc REGN2.77%3.91%2.77%
Boston Scientific Corp BSX2.48%1.42%1.42%
Zimmer Biomet Holdings Inc ZBH2.47%1.42%1.42%
Pfizer Inc PFE2.35%3.84%2.35%
Halozyme Therapeutics Inc HALO1.78%2.30%1.78%
Neurocrine Biosciences Inc NBIX1.67%1.57%1.57%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FXH

  1. Universal Health Services Inc — 2.57%
  2. Solventum Corp — 2.51%
  3. Guardant Health Inc — 2.45%
  4. Davita Inc — 2.44%
  5. Tenet Healthcare Corp — 2.30%
  6. Cigna Group (the) — 2.29%
  7. Globus Medical Inc — 2.26%
  8. Medline Inc — 2.26%
  9. Natera Inc — 2.23%
  10. Corcept Therapeutics Inc — 2.23%
  11. Centene Corp — 2.20%
  12. Axsome Therapeutics Inc — 2.02%
  13. Encompass Health Corp — 1.86%
  14. Medtronic Plc — 1.85%
  15. Resmed Inc — 1.83%

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Abbvie Inc — 4.19%
  3. Eli Lilly & Company — 4.16%
  4. Unitedhealth Group Inc — 3.88%
  5. Merck & Company Inc — 3.68%
  6. Gilead Sciences Inc — 3.54%
  7. Astrazeneca Plc — 3.27%
  8. Elevance Health Inc — 3.25%
  9. Roche Holding Ag — 3.01%
  10. Chugai Pharmaceutical Co Ltd — 2.77%
  11. Viatris Inc — 2.48%
  12. Oruka Therapeutics Inc — 2.41%
  13. Amgen Inc — 2.27%
  14. Illumina Inc — 2.11%
  15. Alkermes Plc — 1.82%

Asset mix

Asset typeFXHDLHIX
Stocks99.8%94.8%
Preferred stock—3.0%
Cash & short-term funds0.2%2.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFXHDLHIX
US93.3%75.4%
BE—5.2%
IE3.3%3.2%
GB—3.3%
CH—3.0%
JP—2.8%
FR—2.0%
NL1.8%1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FXH and DLHIX overlap?
About 19% by weight. 6 securities appear in both funds' top 25 holdings; they make up 13.5% of FXH's assets and 14.5% of DLHIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FXH and DLHIX have in common?
The largest shared holdings are Regeneron Pharmaceuticals Inc, Pfizer Inc, Halozyme Therapeutics Inc, Neurocrine Biosciences Inc, Zimmer Biomet Holdings Inc.
Should I own both FXH and DLHIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FXH or DLHIX?
DLHIX is broader, with 108 positions versus 75 for FXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.